Alignment Healthcare Announces Pricing of Secondary Offering

2 years ago

ORANGE, Calif., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment Healthcare” or the “Company”), a tech-enabled…

Digital Conversations Power the Ultimate Patient Experience

2 years ago

By Greg Kefer at Lifelink Systems For years, BMW has declared their cars the “ultimate driving machine” and for good reason.…

Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit

2 years ago

VANCOUVER and MINNEAPOLIS, Sept. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today…

Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering

2 years ago

HAYWARD, Calif., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or “the Company”), a development-stage, gene…

Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer

2 years ago

New role optimizes resources in cultivation, production and supply chain for maximum outputTORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Entourage…

Wave Life Sciences to Host Analyst and Investor Virtual Event, “Towards the Clinic: Spotlight on RNA Editing for AATD,” on September 28, 2022

2 years ago

Focus on WVE-006, a first-in-class RNA editing development candidate for AATD, and feature AATD expert presentationCAMBRIDGE, Mass., Sept. 16, 2022…

Belite Bio Receives Approval of LBS-008 Phase 3 Clinical Trial in China

2 years ago

LBS-008 (aka Tinlarebant) is Belite Bio’s orally administered tablet for early intervention to maintain the health of retinal tissue in…

Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union

2 years ago

Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY® Original/Omicron BA.4-5 and COMIRNATY®…

Sight Sciences OMNI® Surgical System to Be Featured in Multiple Presentations at the 2022 European Society of Cataract and Refractive Surgery Annual Meeting

2 years ago

Compendium of clinical presentations includes studies with up to 3.5 years of patient follow-up and over 400 eyes treated in…

ORYZON to Present Preliminary Blinded Aggregate Safety Data From Vafidemstat’s Ongoing Phase IIb PORTICO Trial in Borderline Personality Disorder

2 years ago

At the 10th European Conference on Mental Health (ECMH)Company expects to perform an interim analysis in 1Q23MADRID, Spain and BOSTON,…